PFS Partners, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
PFS Partners, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2024$2,938
-6.8%
2270.0%0.00%0.0%
Q1 2024$3,154
-2.7%
2270.0%0.00%0.0%
Q4 2023$3,240
-7.7%
2270.0%0.00%
-33.3%
Q3 2023$3,512
-1.5%
2270.0%0.00%0.0%
Q2 2023$3,567
-4.7%
2270.0%0.00%
-25.0%
Q1 2023$3,741
+5.6%
2270.0%0.00%0.0%
Q4 2022$3,542
+20.3%
2270.0%0.00%
+33.3%
Q3 2022$2,945
-7.6%
2270.0%0.00%0.0%
Q2 2022$3,188
-1.9%
2270.0%0.00%0.0%
Q1 2022$3,251
+5.0%
2270.0%0.00%
+50.0%
Q4 2021$3,0952270.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Y.D. More Investments Ltd 1,498,811$24,700,3805.57%
TFG Asset Management GP Ltd 1,903,662$31,372,3504.20%
Clean Yield Group 542,342$8,937,7963.81%
MANAGED ASSET PORTFOLIOS, LLC 1,467,952$24,1923.67%
Mondrian Investment Partners LTD 4,081,715$67,266,6631.48%
Sippican Capital Advisors 82,235$1,355,2331.30%
Psagot Value Holdings Ltd. / (Israel) 174,300$2,8301.18%
Clal Insurance Enterprises Holdings Ltd 4,365,500$71,9431.08%
Legacy Wealth Asset Management, LLC 123,303$2,032,0330.73%
BRANDES INVESTMENT PARTNERS, LP 1,817,972$29,960,1750.64%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders